ANTHONY J. ROTHSCHILD, MD, NAMED VICE CHAIR OF RESEARCH IN DEPARTMENT OF PSYCHIATRY AT UMASS MEDICAL SCHOOL
June 27, 2005
WORCESTER, Mass.— Anthony J. Rothschild , MD, the Irving S. and Betty Brudnick Professor of Psychiatry at the University of Massachusetts Medical School, has been named Vice Chair for Research in the Department of Psychiatry.
“Dr. Rothschild is not only a skilled clinician and researcher, but an outstanding mentor of junior faculty, and a strong advocate for psychiatric research,” said Paul S. Appelbaum, MD, the Arnold F. Zeleznik Professor of Psychiatry and chair of psychiatry. “He is the perfect person to be appointed to this newly created position.”
A widely recognized expert on psychotic depression, Dr. Rothschild joined the Department of Psychiatry in 1996 and was named its director of clinical research shortly after his appointment. He also founded and directs the Department’s Center for Psychopharmacologic Research and Treatment.
Rothschild has been awarded many research grants and made presentations at numerous international, national and local meetings on the use of antidepressants in treating depressed patients. He is a fellow of the American Psychiatric Association and the American Psychopathological Association and a member of the
of Neuropsychopharmacology, American Society of Clinical Psychopharmocology, and the International Society of Psychoneuro-endocrinology, among other professional organizations.
Rothschild serves as a journal referee for several publications including the American Journal of Psychiatry, Journal of Clinical Psychiatry, Journal of Clinical Psychopharmacology, New
Journal of Medicine, Harvard Review of Psychiatry, Depression
. In 1999, he also contributed a chapter to the book The Best Medicine
regarding his professional relationship with Irving S. Brudnick of Weston, for whom his professorship is named.
Rothschild is an examiner for the American Board of Psychiatry and Neurology, Inc., a mentor for the Program for Minority Research Training in Psychiatry and an ad hoc reviewer for the Department of Veterans Affairs Merit Review. In addition to the biology and treatment of depression, Rothschild’s other research interests include the sexual dysfunction side effects of antidepressants. His work in this area has generated national media attention concerning his research study that found beneficial effects of “drug holidays” (discontinuing antidepressant use for 72 hours) on the sex lives of patients with depression.
In 2004, the Massachusetts Psychiatric Society awarded its prestigious Outstanding Psychiatrist Award to Rothschild, one of just six professionals chosen statewide for their exceptional service in the areas of research, clinical psychiatry, public sector work, advancement of the profession, education and lifetime achievement.
A 1975 graduate of
, Dr. Rothschild received his medical degree from the University of Pennsylvania School of Medicine. Before coming to UMMS, he was an associate professor of psychiatry at
, clinical director of Ambulatory Services, associate director of the Depression Research Facility, and associate director of the Psychopharmacology Service at
The University of Massachusetts Medical School, one of the fastest growing academic health centers in the country, has built a reputation as a world-class research institution, consistently producing noteworthy advances in clinical and basic research. The
attracts more than $173 million in research funding annually, 80% of which comes from federal funding sources. Research funding enables UMMS scientists to explore human disease from the molecular level to large-scale clinical trials. Basic and clinical research leads to new approaches for diagnosis, treatment and prevention of disease. UMMS is the academic partner of UMass Memorial Health Care, the largest health care system in
. For more information go to www.umassmed.edu and www.umassmemorial.org .
Contact: Public Affairs and Publications, (508) 856-2000